share_log

Eli Lilly and Co | 8-K: Estimated Third Quarter Acquired In-Process Research and Development and Development Milestone Charges

Oct 12, 2022 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more